
Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy
Author(s) -
Hamed Elgendy,
Hanaa Nafady-Hego,
Hanan M. Abd Elmoneim,
Talha Youssef,
Abdulaziz M. Alzahrani
Publication year - 2019
Publication title -
indian journal of anaesthesia/indian journal of anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.645
H-Index - 30
eISSN - 0976-2817
pISSN - 0019-5049
DOI - 10.4103/ija.ija_324_19
Subject(s) - medicine , perioperative , hyperthermic intraperitoneal chemotherapy , surgery , confidence interval , hazard ratio , partial thromboplastin time , univariate analysis , multivariate analysis , cancer , cytoreductive surgery , coagulation , ovarian cancer
The existence of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as a multidisciplinary approach for peritoneal cancer gains acceptance in many countries including Saudi Arabia. The aim of our study is to describe the perioperative management of patients who received CRS/HIPEC and to report their outcomes and complications at our tertiary centre.